Created in 2011 (United States), PANOPLIN own
61 sister brands
and 17479 competing brands.
The PANOPLIN brand is owned by Biogen Idec, a company listed in New York.
PANOPLIN is part of the Drug Manufacturers activity sector.
PANOPLIN is a brand of Biogen Idec (BIIB) Other brands